Organisation paid for research Program year 2025 Source: CMS Open Payments

NYU Langone

Neither a doctor nor a teaching hospital

Research payments

$301,270

28 payments

Through program year 2025, NYU Langone is reported as receiving $301,270 in research payments, across 28 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$5,464	2
2024	Research	$420	1
2023	Research	$222,383	16
2020	Research	$15,126	4
2019	Research	$57,877	5

Breakdown

Who paid Research payments · program years 2019–2025

Shockwave Medical, Inc $219,929 15 payments
Mallinckrodt Enterprises LLC $47,601 3 payments
Amgen Inc. $26,550 6 payments
Dexcom, Inc. $4,500 1 payment
E.R. Squibb & Sons, L.L.C. $1,384 2 payments
Medtronic Vascular, Inc. $1,307 1 payment

Studies the money was for Research payments · program years 2019–2025

Disrupt PAD BTK II $219,929 15 payments
A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Confirm Efficacy and Safety of Terlipressin in Subjects With Hepatorenal Syndrome Type 1 $47,601 3 payments
AMG 510_P1/2 Monotherapy NSCLC/CRC/Tumor Agnostic_20170543 $13,819 3 payments
AMG 510_P1/2 Monotherapy NSCLC/CRC/Tumor Agnostic_20170543. $10,276 2 payments
A Prospective, Randomized, Non-Blinded Study of the Effect of Continuous Glucose Monitoring on Glycemic Management in Patients New-To-Insulin on Hospital Discharge $4,500 1 payment
AMG 305 FIH solid tumors $2,454 1 payment
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (POETYK SLE-2) $1,384 2 payments
Symplicity AF $1,307 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.